Reske S N, Sauer W, Machulla H J, Knust J, Winkler C
Eur J Nucl Med. 1985;10(5-6):228-34. doi: 10.1007/BF00254466.
The uptake and turnover of omega(p 123I iodophenyl-)pentadecanoic acid (I-PPA), a radioiodinated free-fatty-acid analog, was examined in the heart, lung, liver, kidneys, spleen, and skeletal muscle of rats. At 2 min post injection, a high cardiac uptake of 4.4% dose per gram had already been achieved; this was followed by a rapid, two-component, tracer clearance. The kinetics of tissue concentrations of labeled hydrophilic catabolites indicated a rapid oxidation of I-PPA and the subsequent washout of I-PPA catabolites from heart-muscle tissue. The fractional distribution of the labeled cardiac lipids compared favorably with previously reported values for 3H-oleic- or 14C-palmitic-acid-labeled myocardial lipids. Typical patterns of I-PPA metabolism were observed in tissues depending on primary fatty-acid oxidation, lipid metabolism regulation, or I-PPA-catabolite excretion. The tissue concentrations and kinetics of I-PPA and its metabolites in the heart muscle indicated that general pathways of cardiac-lipid metabolism are traced by this new gamma-emitting isotope-labeled radiopharmaceutical.
对放射性碘化游离脂肪酸类似物ω-(对碘苯基)十五烷酸(I-PPA)在大鼠心脏、肺、肝脏、肾脏、脾脏和骨骼肌中的摄取及周转情况进行了研究。注射后2分钟,心脏每克组织摄取量已达4.4%剂量;随后出现快速的双组分示踪剂清除。标记亲水性代谢物的组织浓度动力学表明I-PPA迅速氧化,随后I-PPA代谢物从心肌组织中被清除。标记心脏脂质的分数分布与先前报道的3H-油酸或14C-棕榈酸标记心肌脂质的值相比良好。根据主要脂肪酸氧化、脂质代谢调节或I-PPA代谢物排泄情况,在组织中观察到了I-PPA代谢的典型模式。I-PPA及其代谢物在心肌中的组织浓度和动力学表明,这种新的发射γ射线的同位素标记放射性药物可追踪心脏脂质代谢的一般途径。